Stock Earnings

Question 1

Quels sont les états financiers clés de LENZ Therapeutics Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), LENZ Therapeutics Inc a un total d'actifs de $215, un bénéfice net loss de $-49

Question 2

Quels sont les ratios financiers clés pour LENZ ?

Accepted Answer

Le ratio de liquidité de LENZ Therapeutics Inc est 19.54, la marge nette est 0, les ventes par action sont de $0.

Question 3

Comment les revenus de LENZ Therapeutics Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Currently LENZ Therapeutics Inc data is not available.

Question 4

LENZ Therapeutics Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, LENZ Therapeutics Inc a un bénéfice net loss de $-49

Question 5

LENZ Therapeutics Inc a-t-elle des passifs ?

Accepted Answer

yes, LENZ Therapeutics Inc a un passif de 11

Question 6

Combien d'actions en circulation LENZ Therapeutics Inc a-t-elle ?

Accepted Answer

LENZ Therapeutics Inc a un total d'actions en circulation de 27.51

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	5	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	39	28	40	32	22	4
Research & Development	27	29	32	72	37	9
Operating Expenses	66	58	73	105	60	13
Other Non Operating Income (Expenses)	0	0	0	4	-10	-54
Pretax Income	-51	-49	-124	-101	-70	-68
Income Tax Expense	0	0	--	--	--	--
Net Income	-52	-49	-124	-101	-70	-68
Net Income Growth	-28%	-60%	23%	44%	3%	--
Shares Outstanding (Diluted)	28.07	21.28	8.14	54.87	28.92	58.08
Shares Change (YoY)	10%	161%	-85%	90%	-50%	0%
EPS (Diluted)	-1.86	-2.33	-15.3	-1.84	-2.45	-1.18
EPS Growth	-34%	-85%	732%	-25%	108%	--
Free Cash Flow	-47	-59	-100	-94	-58	-10
Free Cash Flow Per Share	-1.67	-2.77	-12.27	-1.71	-2	-0.17
Gross Margin	--	--	--	--	--	--
Operating Margin	-1,220%	0%	0%	0%	0%	0%
Profit Margin	-1,040%	0%	0%	0%	0%	0%
Free Cash Flow Margin	-940%	0%	0%	0%	0%	0%
EBITDA	-61	-58	-71	-103	-60	-13
EBITDA Margin	-1,220%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	2	2	0	0
EBIT	-61	-58	-73	-105	-60	-13
EBIT Margin	-1,220%	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	--	--	--	--

LENZ Therapeutics Inc (LENZ) Price